tiprankstipranks
Ventripoint Diagnostics Revises Convertible Debenture Plans
Company Announcements

Ventripoint Diagnostics Revises Convertible Debenture Plans

Story Highlights

VentriPoint Diagnostics (TSE:VPT) has released an update.

Pick the best stocks and maximize your portfolio:

Ventripoint Diagnostics has announced its plan to issue common shares to satisfy interest payments on its convertible debentures, pending approval from the TSXV. Additionally, the company has revised the terms of its convertible debenture offering, adjusting conversion rates over the term’s duration.

For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskVentripoint Closes Debt Settlement with Share Issuance
TipRanks Canadian Auto-Generated NewsdeskVentripoint Launches U.S. Sales Program for AI Solutions
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App